Skip to main content

letter

. 1986 Jun 21;292(6536):1667–1668. doi: 10.1136/bmj.292.6536.1667-a

Oral contraceptives and hepatocellular carcinoma

PMCID: PMC1340724 PMID: 3013358

1667

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Badaracco M., Vessey M. P., Wiggins P. The effect of the statement by the Committee on Safety of Drugs concerning oral contraceptives containing oestrogens on the contraceptive practices of women attending two family planning clinics. J Obstet Gynaecol Br Commonw. 1973 Apr;80(4):353–356. doi: 10.1111/j.1471-0528.1973.tb11207.x. [DOI] [PubMed] [Google Scholar]
Forman D., Doll R., Peto R. Trends in mortality from carcinoma of the liver and the use of oral contraceptives. Br J Cancer. 1983 Sep;48(3):349–354. doi: 10.1038/bjc.1983.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
Goodman Z. D., Ishak K. G. Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids. Hepatology. 1982 Jul-Aug;2(4):440–444. doi: 10.1002/hep.1840020408. [DOI] [PubMed] [Google Scholar]
Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES